Twenty-nine companies and universities in the U.K. now have funding to tackle healthcare challenges ranging from cancer to childbirth complications. Projects supported include:
This follows 23 separate feasibility awards, totaling over $4.7 million, made earlier in 2014. It brings total investment via the Biomedical Catalyst to over $314 million since it was launched in 2012. It has leveraged a further $157 million in industry co-commitment and supported innovation from some 250 SME companies and universities.